All lobbying filings

Bose Public Affairs Group

Bose Public Affairs Group filed a Q1 report for Glenmark Pharmaceuticals on April 20, 2026, reporting $20,000 in lobbying income.

Lobbying for Glenmark Pharmaceuticals · Generic pharmaceuticals manufacturer

As filed: BOSE PUBLIC AFFAIRS GROUP for GLENMARK PHARMACEUTICALS.

All filings by Bose Public Affairs Group · Everything Glenmark Pharmaceuticals has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 1

DAVID CRANE

Previously held: Senior Policy Advisor, Senate Majority Leader, Senate Republican Leader, Professional Staff, Senate Commerce Committee, Legislative Director, Senator Dan Coats, Legislative Assistant Senator Dan Coats

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to domestic pharmaceutical manufacturing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.